Idexx Laboratories (IDXX) Enterprise Value (2009 - 2026)

Idexx Laboratories' Enterprise Value history runs 18 years deep, the most recent figure standing at -$200.5 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 22.3% year-over-year to -$200.5 million; the TTM figure through Mar 2026 stood at -$200.5 million (down 22.3% YoY), while the FY2025 annual figure was -$180.1 million, up 37.53% from the prior year.
• Enterprise Value for Q1 2026 stood at -$200.5 million, down from -$180.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$99.2 million in Q3 2022, with the low at -$453.9 million in Q4 2023.
• The 5-year median for Enterprise Value is -$200.5 million (2026), against an average of -$227.9 million.
• The sharpest annual moves came in 2023 and 2025: Enterprise Value slumped 303.33% in 2023, then surged 59.01% in 2025.
• Idexx Laboratories' Enterprise Value stood at -$112.5 million in 2022, then plunged by 303.33% to -$453.9 million in 2023, then jumped by 36.5% to -$288.3 million in 2024, then jumped by 37.53% to -$180.1 million in 2025, then retreated by 11.36% to -$200.5 million in 2026.
• Business Quant data shows IDXX's Enterprise Value at -$200.5 million in Q1 2026, -$180.1 million in Q4 2025, and -$208.2 million in Q3 2025.